ArticleChinese medicine2022

Toosendanin, a late-stage autophagy inhibitor, sensitizes triple-negative breast cancer to irinotecan chemotherapy.

Shuang Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.